Dr. Olivia Wu

Biography

Olivia holds the William R Lindsay Chair in Health Economics (Health Economics & Health Technology Assessment) at the University of Glasgow and is an Adjunct Professor at the Faculty of Pharmacy, Mahidol University, Thailand. She is an elected Fellow of the Royal Society of Edinburgh. Olivia has expertise in a broad range of health technology assessment (HTA) methodologies and is interested in adapting and applying HTA methodologies in various contexts. Her research is multidisciplinary in nature, spanning a wide range of clinical areas and types of health interventions, including pharmacological treatments, medical devices, diagnostic tests, and digital health interventions. She has led numerous health economic evaluations alongside clinical evaluations and trials, which have informed clinical guidelines and health policy decisions at national and international levels. Olivia’s work focuses on the effective use of evidence synthesis approaches to maximize the value of existing data in informing clinical and economic evaluations. Currently, she leads the Complex Reviews Synthesis Unit (CRSU), which hosts nine Evidence Synthesis Groups funded by the National Institute for Health Care Research (NIHR). Olivia is also heavily involved as a co-investigator in active research projects with a cumulative value of £50 million and is a long-standing advisor to HTA agencies in the UK. Her commitment to developing an inclusive environment for the next generation of researchers in the UK is reflected in her roles within various mentorship initiatives.

Research Interests

Experience